SK Bioscience Co (XKRX:302440) Days Payable : 32.17 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is SK Bioscience Co Days Payable?

SK Bioscience Co's average Accounts Payable for the three months ended in Mar. 2024 was ₩5,949 Mil. SK Bioscience Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ₩16,874 Mil. Hence, SK Bioscience Co's Days Payable for the three months ended in Mar. 2024 was 32.17.

The historical rank and industry rank for SK Bioscience Co's Days Payable or its related term are showing as below:

XKRX:302440' s Days Payable Range Over the Past 10 Years
Min: 11.48 Med: 50.47 Max: 82.58
Current: 11.48

During the past 6 years, SK Bioscience Co's highest Days Payable was 82.58. The lowest was 11.48. And the median was 50.47.

XKRX:302440's Days Payable is ranked worse than
96.12% of 721 companies
in the Biotechnology industry
Industry Median: 148.28 vs XKRX:302440: 11.48

SK Bioscience Co's Days Payable declined from Mar. 2023 (41.96) to Mar. 2024 (32.17). It may suggest that SK Bioscience Co accelerated paying its suppliers.

SK Bioscience Co Days Payable Historical Data

The historical data trend for SK Bioscience Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Bioscience Co Days Payable Chart

SK Bioscience Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

50.67

50.26

41.37

62.93

11.58

SK Bioscience Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															41.96	29.83	5.89	10.20	32.17

Competitive Comparison of SK Bioscience Co's Days Payable

For the Biotechnology subindustry, SK Bioscience Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SK Bioscience Co's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SK Bioscience Co's Days Payable distribution charts can be found below:

* The bar in red indicates where SK Bioscience Co's Days Payable falls into.

SK Bioscience Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

SK Bioscience Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (11053.234	+	3370.136)	/	2 )	/	227262.754	*	365
=	7211.685					/	227262.754	*	365
=	11.58

SK Bioscience Co's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (3370.136	+	8527.032)	/	2 )	/	16874.421	*	365 / 4
=	5948.584					/	16874.421	*	365 / 4
=	32.17

SK Bioscience Co Days Payable Related Terms

Thank you for viewing the detailed overview of SK Bioscience Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

SK Bioscience Co (XKRX:302440) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Bioscience Co Ltd (XKRX:302440) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

310, Pangyo-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494

Website

https://www.skbioscience.co.kr

SK Bioscience Co Ltd is a South Korean pharmaceutical company. It is engaged in the manufacturing and developing of vaccine. The company has registered SKYCellflu prefilled syringe (PFS), the first cell culture influenza vaccine in Korea, followed by the licensure of SKYCellflu Quadrivalent prefilled syringe and 13-valent Pneumococcal Conjugate Vaccine. Further it has several other vaccines under development and clinical trials including recombinant rotavirus vaccine. In addition, the development of new typhoid conjugate vaccine and innovative pneumococcal vaccine is ongoing in collaboration with external partners.

SK Bioscience Co (XKRX:302440) Headlines

No Headlines